Status:
COMPLETED
Minimally Invasive Surgical Technique in Management of Intrabony Defects
Lead Sponsor:
Misr University for Science and Technology
Conditions:
Periodontal Diseases
Eligibility:
All Genders
30-50 years
Phase:
NA
Brief Summary
In the fast-growing era of contemporary periodontology, the understanding of biological concepts in wound healing together with the evolution of the flap design and biomaterials applied in periodontal...
Eligibility Criteria
Inclusion
- Patient age ranged from 30 to 50 years old for both genders.
- Patients are medically free according to the American society of anesthesiologists (ASA) considered as ASA I.
- The selected participants with a diagnosis stage III grade B periodontitis.
- Defect morphology: Isolated interproximal infrabony defect of at least 5mm CAL which does not extend beyond the adjacent interproximal region.
- Optimal compliance as assessed during the case related phase I therapy and evidenced by no missed treatment appointments and positive attitude toward oral hygiene.
- Bleeding on probing \<25%.
Exclusion
- Smoker and pregnant patients.
- Multiple, interconnected vertical defects.
- Generalized horizontal bone defects.
- Teeth with incorrect endodontic treatment or restoration.
- Stage I, II or IV periodontitis.
- Patient who need complex prosthetic rehabilitation.
Key Trial Info
Start Date :
May 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 21 2024
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06591416
Start Date
May 2 2023
End Date
August 21 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta university
Tanta, Gharbia Governement, Egypt, 6620010